Delivery Order SPE2DB22D3501-SPE2DB25FXF09
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,939.34 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- The Defense Logistics Agency awarded a delivery order valued at $1,124.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, to supply Naloxone 4 mg/10 mL vials with a ceiling value of $9,855.31 and a firm fixed price contract type. The order was completed as a child delivery order under a larger indefinite delivery contract vehicle with an ultimate completion date of August 26, 2025. This non-competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Naloxone 4 mg/10 mL vials with a ceiling value of $11,898.39 and a firm fixed price structure. This is a competitively awarded, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $1,018.53 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Naloxone 0.4 mg/mL vials. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF09Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $1,055.25. This is a firm fixed price, non-competitive set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for naloxone, an opioid antagonist medication commonly used for emergency overdose treatment, represents a routine fulfillment under this extensive pharmaceutical supply contract supporting Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/8/25 |